The Federal Register

Proposed Data Collections Submitted for Public Comment and Recommendations

Thu, Dec 20 2007 11:00:00 GMT

In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 4046395960 and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MSD74, Atlanta, GA 30333 or send an email to omb@cdc.gov.

Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collecte

Proposed Data Collections Submitted for Public Comment and Recommendations

Thu, Dec 20 2007 11:00:00 GMT

Submission for OMB Review; Comment Request

Thu, Dec 20 2007 11:00:00 GMT

Title: Information Comparison with Insurance Data.

OMB No.: New Collection.

Description: The Deficit Reduction Act of 2005 amended section 452 of the Social Security Act (the Act) to authorize the Secretary of Health and Human Services, through the Federal Parent Locator Service (FPLS), to conduct comparisons of information concerning individuals owing pastdue child support with information maintained by insurance companies (or their agents) concerning insurance claims, settlements, awards, and payments. The Federal Office of Child Support Enforcement (OCSE) operates the FPLS in accordance with section 453(a)(1) of the Act. The Federal Case Registry of Child Support Orders (FCR) is maintained in the FPLS in accordance with section 453(h)(1) of the Act.

At the option of an insurer, the comparison may be accomplished by either of the following methods: under the first method, an insurer or the insurer's agent will submit to OCSE information concerning claims, settlements, awards, an

National Cancer Institute; Notice of Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Institute Director's Consumer Liaison Group.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations should notify the Contact Person listed below in advance of the meeting.

Name of Committee: National Cancer Institute Director's Consumer Liaison Group.

Date: January 24, 2008.

Time: 1 p.m. to 3 p.m.

Agenda: 1. Approval of Minutes; 2. Reports from Dr. John E. Niederhuber, NCI Director; 3. Report from Shannon Bell, OAR Director; 4. Discussion of Recommendations at DCLG October inperson meetings; 5. Reports from DCLG members of NCI Committee Assignments; 6. Public Comment; 7. Action Items and Conclusion.

Place: National Institutes of Health, 61l6 Executive Bo

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as aamended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. [[Page 72366]]

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, ``Bcell P01 appplications''.

Date: January 10, 2008.

Time: 12 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, ``Host Response to Pathogens''.

Date: January 10, 2008.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).

Contact Pe

National Institute of Dental & Craniofacial Research; Notice of Closed Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, National Institute of Dental and Craniofacial Research.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Dental & Craniofacial Research, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Board of Scientific Counselors, National Institute of Dental and Craniofacial Research.

Date: January 68, 2008.

Time: January 6, 2008, 5 p.m. to 9:30 p.m.

Agenda: To review and evaluate personal qualifications and

National Institute of Nursing Research; Notice of Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council for Nursing Research.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: Nationa

National Advisory Council on Drug Abuse; Notice of Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council on Drug Abuse.

Name of Committee: National Advis

National Institute On Drug Abuse; Notice of Closed Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. [[Page 72367]]

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Design and Synthesis of Treatment Agents for Drug Abuse.

Date: December 18, 2007.

Time: 10:20 a.m. to 1 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

National Institute on Drug Abuse; Notice of Closed Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, MIDARP.

Date: January 10, 2008.

Time: 10 a.m. to 11 a.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Nadine Rogers, PhD, Scientific Review Administra

Office Of The Director, National Institutes Of Health; Notice of Meeting

Thu, Dec 20 2007 11:00:00 GMT

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: Recombinant DNA Advisory Committee.

Date: January 14, 2008.

Time: 3 p.m. to 4 p.m.

Agenda: Recombinant DNA Advisory Committee teleconference will meet to discuss the followup of a Serious Adverse Event on a Human Gene Transfer Trial (OBA Protocol 0504705) Using an Adeno Associated Viral Vector: Analysis of Its Scientific and Safety Implications.

Place: National Institutes of Health, Building 31, 31 Center Drive, Sixth Floor, C Wing, Room 6, Bethesda, MD 20892, (Telephone Conference Ca